A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.Francis G. LeVeque, Charles C. Muscoplat, Margaret A. Montgomery et al.|Journal of Clinical Oncology|1993Cited by 292
Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trialsJohn W. Rieke, Susan C. Gallagher, Jonas T. Johnson et al.|International Journal of Radiation Oncology*Biology*Physics|1995Cited by 139